Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-spanning 4-domains subfamily A member 3 (MS4A3) is a human protein encoded by the MS4A3 gene, a member of the membrane-spanning 4A gene family, which is defined by a common structural motif with four transmembrane domains. MS4A3 is predominantly expressed in hematopoietic cells and may serve as a modulator for the G1-S transition of the cell cycle by influencing cyclin-dependent kinase 2 (CDK2) activity, through direct interaction with cyclin-dependent kinase inhibitor 3 (CDKN3). Though included in studies of immune signaling and cell-cycle regulation, there are no approved drugs or therapeutic agents currently targeting MS4A3 directly. Disease associations include hereditary essential tremor and intellectual developmental disorders, though its precise roles in broader immunological or hematological diseases are still being characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-spanning 4-domains subfamily A member 3 (MS4A3).